Long-term oxygen therapy has been proven to improve survival in COPD patients with severely impaired oxygenation. However, does the COPD patient with moderately impaired oxygenation also benefit from supplemental long-term oxygen therapy? The Long-Term Oxygen Treatment Trial (LOTT), a randomized clinical trial published in 2016, was designed to evaluate the efficacy of supplemental oxygen for this patient population. This presentation will discuss the design and results of the multi-center LOTT and the implications on patient care.
Successful completion of this course requires a score of 70% on the post-test.
This webcast is sponsored by an unrestricted educational grant from ResMed Inc.
Original Webcast Date June 6, 2017
**Please note that all programs require the participant to view the entire program prior to taking the final quiz and obtaining a course certificate.**
Approved for 1.00 CRCE Hours.